March’s top stories: AstraZeneca’s Faslodex received FDA approval, Teva acquired Rimsa

4
Image: Sun Pharma’s global presence is supported by 49 manufacturing facilities across six continents. Photo: courtesy of Sun Pharmaceutical Industries.